molecular cancer therapeutics | Journament

Journal Ranking

Unranked

Not Yet Ranked

Quality metrics need to be calculated to establish ranking.

Sign In to Calculate Scores Authentication required

molecular cancer therapeutics

Indexings
ncbi ulakbim sci
Short Name mol cancer ther
Abbreviated Name mol cancer ther
ISSN 1538-8514
Aim and Scope
URL
Author Instructions

Publications Per Year

Recent Articles (1 total)

2019
Ibrutinib potentiates anti-hepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma.
Lin, Cho-Hao;Elkholy, Khadija H;Wani, Nissar A;Li, Ding;Hu, Peng;Barajas, Juan M;Yu, Lianbo;Zhang, Xiaoli;Jacob, Samson T;Khan, Wasif N;Bai, Xue-Feng;Noonan, Anne M;Ghoshal, Kalpana;
342 views DOI Abstract
0
Overall
Not Rated
0
0
0
0
0
0
0
0
0
0
0
Journament